To the extent possible under law, the person who associated CC0 with this work has waived all copyright and related or neighboring rights to this work.
DRAVP ID DRAVPa1777
Peptide Name Sequence 8 from Patent US20150337015 B2
Sequence SWNFFDWFSGLMSWFGGPLK
Sequence Length 20
Source Synthetic construct
Target Organism RVFV
Patent Type Granted Patent
Publication Date 2017-01-31
Patent No US20150337015 B2
Family Info WO/2014/123614
Patent Title Antiviral rift valley fever virus peptides and methods of use
Comment
Abstract The invention entails synthetic short peptides based on Rift Valley Fever Virus (RVFV) fusion protein. The peptides are broad-spectrum antivirals, and are useful for prophylactic treatment against or therapeutic treatment of infection by hemorrhagic fever viruses, such as RVFV, Ebola Virus, and Andes Virus, as well as vesicular stomatitis virus.
To the extent possible under law, the person who associated CC0 with this work has waived all copyright and related or neighboring rights to this work.